Filing Flows › P3 Health Partners (PIII) › Guidance & outlook
P3 Health Partners (PIII) guidance and outlook
P3 Health Partners' 10-Q filed Nov 9, 2026 makes 25 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 9, 2026
- Our historical results are not necessarily indicative of the results that may be expected for any periods in the future.
- We predominantly enter into capitated contracts with the nation’s largest health plans to provide holistic, comprehensive healthcare to MA members.
- In this capitated arrangement, our goals are well-aligned with payors and patients alike—the more we improve health outcomes, the more profitable we will be over time.
- However, we have and intend to continue to conduct
- We expect that our PMPM revenue will continue to improve the longer members participate in our care model as we better understand and assess their health status (acuity) and coordinate their medical care.
- As a result of our affiliate model and ability to leverage our existing local and national infrastructure, we aim to generate operating efficiencies at both the market and enterprise level.
- Our local corporate, general and administrative expense, which includes our local leadership, care management teams and other operating costs to support our markets, is expected to decrease over time as a percentage of revenue as we add members to our existing contracts, grow membership with new payor and physician contracts, and our revenue subsequently increases.
- While we expect our absolute investment in our enterprise resources to increase over time, we expect our investment will decrease as a percentage of revenue when we are able to leverage our infrastructure across a broader group of at-risk members.
- We expect our corporate, general and administrative expenses to increase in absolute dollars in the future as we continue to invest to support growth of our business, as well as due to the costs required to operate as a public company, including insurance coverage, investments in internal audit, investor relations and financial reporting functions, fees paid to the Nasdaq Stock Market, and increased legal and…
- We would therefore expect to see higher levels of per-member medical expense in the first and fourth quarters.
- Our presentation of these measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items.
- As our platform grows and matures over time, we expect medical margin to increase in absolute dollars; however, medical margin PMPM may vary as the percentage of new members brought onto our platform fluctuates.
P3 Health Partners' latest quarter
P3 Health Partners, Q3 2026: revenue $396M (+15% year over year), operating margin 5.8%, net earnings $15.6M, operating cash flow −$685K. The chart follows the revenue to costs, profit and cash.
Questions
What does P3 Health Partners expect?
Our historical results are not necessarily indicative of the results that may be expected for any periods in the future. We predominantly enter into capitated contracts with the nation’s largest health plans to provide holistic, comprehensive healthcare to MA members. In this capitated arrangement, our goals are well-aligned with payors and patients alike—the more we improve health outcomes, the more profitable we will be over time.
Updated Nov 9, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.